よむ、つかう、まなぶ。
Global Health Vision of Ministry of Health, Labour and Welfare of Japan (22 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_42939.html |
| 出典情報 | 「厚生労働省国際保健ビジョン」の公表について（8／26）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
expansion of pharmaceuticals and medical devices by utilizing procurement
frameworks of international organizations. Furthermore, the objective of providing
advanced medical care to foreign visitors to Japan (medical inbound) is to address
health disparities in Asia and other regions, ensure that the benefits of innovation are
widely distributed among the public, and extend Japan's healthcare model across Asia.
This will lay the groundwork for improving and disseminating the quality of medical
devices, pharmaceuticals, and other products. In collaboration with the relevant
ministries and organizations related to medical inbound 6 , we will promote efforts
towards achieving these goals by conducting assessments and analyses of the
current situation and challenges, and set strategic goals to maintain and advance
cutting-edge medical technologies while organizing and promoting the acceptance of
foreign patients.
③ Timeline
We will begin examining a demonstration project for establishing a model for
accepting foreign students into Japanese medical schools, utilizing scholarships
funded by contributions to ERIA from the fiscal year 2024.
Regarding the promotion of the foreign patients acceptance system at medical
institutions, we will continue implementing the project through private companies and
relevant agencies in the fiscal year 2024, with the aim of expanding it in subsequent
years.
For the international expansion of medical technologies, the project will continue in
the fiscal year 2024 through NCGM7 and private companies, with a view to expanding
to the Asian region and beyond in the following years.
The research projects on the practical application of medical technologies in
developing and emerging countries through private companies and relevant agencies
will continue to be implemented in the fiscal year 2024, with plans for expansion in
subsequent years.
The promotion of international expansion of pharmaceutical and medical device
6
The Japan Medical Education Foundation (JMIP) certifies medical institutions that provide foreigners
with safe and secure medical services in Japan, such as multilingual medical information and crosscultural/religious support, and recommends hospitals that are willing and able to receive travelers as
Japan International Hospitals (JIH). Medical Excellence Japan (MEJ), which recommends hospitals that are
willing and able to receive travelers as Japan International Hospitals (JIH).
7
JIHS will be established in April 2025 through the merger of the National Institute of Infectious
Diseases and NCGM.
22
frameworks of international organizations. Furthermore, the objective of providing
advanced medical care to foreign visitors to Japan (medical inbound) is to address
health disparities in Asia and other regions, ensure that the benefits of innovation are
widely distributed among the public, and extend Japan's healthcare model across Asia.
This will lay the groundwork for improving and disseminating the quality of medical
devices, pharmaceuticals, and other products. In collaboration with the relevant
ministries and organizations related to medical inbound 6 , we will promote efforts
towards achieving these goals by conducting assessments and analyses of the
current situation and challenges, and set strategic goals to maintain and advance
cutting-edge medical technologies while organizing and promoting the acceptance of
foreign patients.
③ Timeline
We will begin examining a demonstration project for establishing a model for
accepting foreign students into Japanese medical schools, utilizing scholarships
funded by contributions to ERIA from the fiscal year 2024.
Regarding the promotion of the foreign patients acceptance system at medical
institutions, we will continue implementing the project through private companies and
relevant agencies in the fiscal year 2024, with the aim of expanding it in subsequent
years.
For the international expansion of medical technologies, the project will continue in
the fiscal year 2024 through NCGM7 and private companies, with a view to expanding
to the Asian region and beyond in the following years.
The research projects on the practical application of medical technologies in
developing and emerging countries through private companies and relevant agencies
will continue to be implemented in the fiscal year 2024, with plans for expansion in
subsequent years.
The promotion of international expansion of pharmaceutical and medical device
6
The Japan Medical Education Foundation (JMIP) certifies medical institutions that provide foreigners
with safe and secure medical services in Japan, such as multilingual medical information and crosscultural/religious support, and recommends hospitals that are willing and able to receive travelers as
Japan International Hospitals (JIH). Medical Excellence Japan (MEJ), which recommends hospitals that are
willing and able to receive travelers as Japan International Hospitals (JIH).
7
JIHS will be established in April 2025 through the merger of the National Institute of Infectious
Diseases and NCGM.
22